Frazier Life Sciences VIII, L.P.
Insider CIK 1655827 · ALPN 10% owner · APTX 10% owner · ETTX 10% owner · ARQT 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ARQT Arcutis Biotherapeutics, I | P Buy | 2023-10-24 | 2023-10-26 | 80,000 | $2.50 | $200.0K | 8,764,232 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2022-08-05 | 2022-08-09 | 250,000 | $20.00 | $5.00M | 8,684,232 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | P Buy | 2022-02-11 | 2022-02-15 | 112,665 | $7.10 | $799.9K | 1,484,115 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2021-09-17 | 2021-09-21 | 1,200,000 | — | $0 | 1,200,000 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer | 2021-09-17 | 2021-09-21 | 1,200,000 | — | $0 | 1,371,450 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | J Other | 2021-05-10 | 2021-05-12 | 96,574 | — | $0 | 96,574 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | J Other | 2021-05-10 | 2021-05-12 | 96,574 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | J Other | 2021-05-10 | 2021-05-12 | 2,108,558 | — | $0 | 8,434,232 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion deriv | 2020-02-04 | 2020-02-06 | 2,099,019 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion deriv | 2020-02-04 | 2020-02-06 | 6,360,272 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion deriv | 2020-02-04 | 2020-02-06 | 1,074,467 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion | 2020-02-04 | 2020-02-06 | 6,360,272 | — | $0 | 6,869,304 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion | 2020-02-04 | 2020-02-06 | 2,099,019 | — | $0 | 8,968,323 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion | 2020-02-04 | 2020-02-06 | 1,074,467 | — | $0 | 10,042,790 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2020-02-04 | 2020-02-06 | 500,000 | $17.00 | $8.50M | 10,542,790 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | S Sale | 2020-01-09 | 2020-01-13 | 50,000 | $5.00 | $250.0K | 1,299,953 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | P Buy deriv | 2019-01-18 | 2019-01-22 | 145,251 | — | $0 | 145,251 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | P Buy | 2019-01-18 | 2019-01-22 | 372,439 | $5.37 | $2.00M | 2,571,450 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 7,000,000 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 5,212,833 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 6,651,574 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 320,898 | — | $0 | 974,066 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 251,487 | — | $0 | 589,194 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 337,707 | — | $0 | 337,707 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | P Buy | 2018-09-28 | 2018-10-02 | 375,887 | $15.00 | $5.64M | 1,349,953 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 21,946,301 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 28,895,188 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 33,022,786 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 1,197,076 | — | $0 | 2,244,526 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 795,553 | — | $0 | 3,040,079 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 1,047,450 | — | $0 | 1,047,450 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2018-06-25 | 2018-06-26 | 150,000 | $16.00 | $2.40M | 3,190,079 | SEC↗ |